Jean-Yves Masson
Chercheur universitaire
Axe Oncologie
Dernières nouvelles
Voir tout
Publications
Voir tout-
article Muhammad AA, Basto C, Peterlini T, Guirouilh-Barbat J, Thomas M, Veaute X, Busso D, Lopez B, Mazon G, Le Cam E, Masson JY, Dupaigne P
Human RAD52 stimulates the RAD51-mediated homology search
Life Sci Alliance 7 (3), 2024.
-
article Mashayekhi F, Ganje C, Caron MC, Heyza JR, Gao Y, Zeinali E, Fanta M, Li L, Ali J, Mersaoui SY, Schmidt JC, Godbout R, Masson JY, Weinfeld M, Ismail IH
PNKP safeguards stalled replication forks from nuclease-dependent degradation during replication stress
Cell Rep 43 (12), 2024.
-
article Yates M, Marois I, St-Hilaire E, Ronato DA, Djerir B, Brochu C, Morin T, Hammond-Martel I, Gezzar-Dandashi S, Casimir L, Drobetsky E, Cappadocia L, Masson JY, Wurtele H, Maréchal A
SMARCAL1 ubiquitylation controls its association with RPA-coated ssDNA and promotes replication fork stability
PLoS Biol 22 (3), 2024.
Projets
- Fonds de cancérologie et ses fonds liés, du 2005-04-01 au 2029-04-30
- Decoding the DNA double-strand break repair pathways: from mechanistic insights to human genome instability diseases, du 2018-07-01 au 2025-06-30
- Personalized Risk Assesment for Prevention and Early Detection of Breast Cancer : Integration and Implementation (PERSPECTIVE II), du 2017-11-01 au 2025-09-30
- Canada Research Chair in DNA repair and Cancer Therapeutics, du 2020-07-01 au 2027-06-30
- Réseau de recherche sur le cancer (RRCancer), du 2023-04-01 au 2026-03-31
- Tumor biobanking was supported by the Banque de tissus et de données en cancers solides of the Réseau de recherche sur le cancer (RRCancer)...The RRCancer is funded by the Oncopole...de l'Économie, de l'Innovation et de l'Énergie du Québec., du 2023-04-01 au 2025-03-31
- Emerging roles of Zinc Finger PAR-Interacting Proteins (ZIPPs) in DNA double-strand break (DSB) repair: implications in PARPi therapy, du 2024-04-01 au 2029-03-31
- Characterization of novel breast cancer susceptibility genes through large-scale targeted sequencing and functional assays., du 2024-04-01 au 2029-03-31
- Caractérisation de nouveaux gènes de susceptibilité au cancer du sein, du 2024-02-15 au 2027-03-31
- Unveiling the roles of Poly(ADP)ribose Glycohydrolase (PARG) in DNA repair and cancer, du 2024-09-01 au 2026-08-31
- Roles of the tumor suppressor PALB2 at the intersection of DNA repair and synthetic lethal strategies in cancer, du 2024-10-01 au 2029-09-30
- Investigating the Role of RECQL in Breast Cancer Susceptibility, du 2017-04-01 au 2024-03-31
- Poly(ADP-ribose) writers, readers, and erasers: Functions in DNA double-strand break repair and synthetic lethality, du 2019-10-01 au 2024-09-30
- Characterization of HR-Killer1 and identification of small molecules for cancer therapy and enhanced gene editing using CRISPR/Cas9-based DNA repair strategies, du 2018-04-01 au 2023-03-31
- Grand prix scientifique, du 2022-04-01 au 2023-03-31
- The contribution of RAD51C and RAD51D to breast and ovarian cancer, du 2021-05-01 au 2023-04-30